GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.27907 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1B1, FABP4, KDR, KIT, MMP9, SRC, TERT |
6.81482 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CHRM1, CYP1B1, DNMT1, FABP3, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, SRC, TERT, XDH |
6.23614 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.23614 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CHRM1, CHRM4, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.6549 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, FABP3, FUT7, PIM1, PPARA, TBXAS1, XDH |
5.14657 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, DNMT1, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PPARA, SRC, TERT |
4.91202 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FUT7, KIT, MET, PPARA, TBXAS1 |
4.91202 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.80849 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.79547 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRM1, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FLT3, KDR, KIT, MET, PPARA, SRC, TERT, XDH |
4.79547 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, FLT3, KDR, KIT, MET, MMP12, MMP9, SRC, TERT, XDH |
4.79423 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, FLT3, KDR, KIT, MET, MMP12, MMP9, SRC, TERT, XDH |
4.78667 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TERT, XDH |
4.77913 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.77333 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.77333 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, SRC, TERT |
4.7139 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TERT, XDH |
4.71129 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, SRC, TERT |
4.69556 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
4.69556 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, FLT3, KIT, MET, PIM1, SRC |
4.673 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, DNMT1, FABP3, FLT3, IGF1R, KIT, MMP2, PPARA, SRC |
4.58493 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.58493 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
4.5794 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, DNMT1, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, PPARA, SRC |
4.54459 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CHRM1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TBXAS1, TERT, XDH |
4.54459 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.52717 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, SRC |
4.38177 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT |
4.38177 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CYP1B1, FLT3, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, SRC, TERT, XDH |
4.28954 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.26048 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
4.19522 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1B1 |
4.18319 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, APP, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, SRC, TERT |
4.16283 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CYP1A1, CYP1B1, DNMT1, FABP3, IGF1R, MMP2, MMP9, PPARA, SRC |
4.16283 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CYP1B1, FLT3, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT, XDH |
4.00782 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CHRM1, CHRM2, CYP19A1, CYP1A1, CYP1B1, DYRK1A, FABP4, FLT3, FUT7, KDR, KIT, MET, MMP2, MMP9, PIM1, PPARA, SRC, TERT |
3.98823 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.96042 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CYP19A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, SRC, TERT, XDH |
3.72143 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.72143 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.72006 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CYP19A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, SRC, TERT, XDH |
3.64597 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CHRM1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIM1, PPARA, SRC, TBXAS1, TERT, XDH |
3.58446 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, SRC, TERT |
3.55841 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CHRM1, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, TERT |
3.55841 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, FABP4, KIT, MMP9, TERT |
3.55584 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.5312 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.41711 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, FLT3, KDR, KIT, MET, MMP12, MMP9, SRC, TERT, XDH |
3.37266 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.35425 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
3.3464 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.34337 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.31871 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CHRM1, CYP19A1, MMP12, SRC, TERT |
3.24171 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1A1, CYP1B1, FABP3, FABP4, FUT7, KIT, MET, PPARA, TBXAS1 |
3.24171 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.24171 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, FABP3, FABP4, FLT3, MET, SRC, TERT |
3.21565 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.21255 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, FLT3, KDR, KIT, MET, SRC, XDH |
3.21255 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
3.19178 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP9, SRC, XDH |
3.17946 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
3.16295 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, FABP3, FLT3, KIT, PPARA, SRC |
3.13136 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, KIT, MMP2, PPARA, SRC, TERT |
3.12319 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CYP1A1, CYP1B1, DNMT1, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PPARA, SRC, TERT |
3.12141 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
3.10255 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CHRM1, CYP19A1, CYP1B1, FABP4, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC |
3.08023 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
3.08023 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.06942 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, IGF1R, KDR, MMP9, PIM1, SRC, TERT |
3.01075 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CHRM1, CHRM2, CYP19A1, CYP1A1, CYP1B1, DYRK1A, FLT3, KDR, KIT, MMP9, PIM1, PPARA, SRC |
2.99376 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, KDR, SRC |
2.9841 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DYRK1A, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, SRC, TERT, XDH |
2.94954 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, FABP4, FLT3, KDR, KIT, MET, MMP12, MMP2, MMP9, SRC, TERT, XDH |
2.91815 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
2.90594 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.88502 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.88502 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CYP1B1, FLT3, IGF1R, KDR, MMP9, PIM1, SRC, TERT, XDH |
2.83263 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, KIT |
2.83263 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, KIT |
2.83263 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.81718 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, FABP3, KDR, SRC |
2.80391 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.78054 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.77564 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.69769 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC |
2.65257 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, SRC, TERT, XDH |
2.64751 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.62637 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.61901 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DYRK1A, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PPARA, SRC, TERT, XDH |
2.5957 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, DNMT1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC |
2.57485 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, MMP12, MMP9, PPARA, SRC, TERT |
2.52988 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.52988 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50212 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.49635 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, KIT |
2.49635 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.46211 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.42001 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.42001 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, KIT, PPARA, SRC |
2.41156 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1 |
2.36253 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
2.35997 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.35997 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.34429 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, XDH |
2.31642 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4 |
2.28919 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.28919 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
2.27317 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.27317 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9 |
2.26776 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4 |
2.2546 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.24174 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.24174 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CHRM1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TBXAS1, TERT, XDH |
2.20745 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20703 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CYP1B1, KDR, KIT, MET, MMP12, MMP9, PIM1, SRC, TERT |
2.20703 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1B1, FABP3, FABP4 |
2.20703 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7 |
2.19458 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CYP1A1, FABP3, FLT3, SRC |
2.19458 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CYP1A1, CYP1B1, FLT3, SRC |
2.17422 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.14454 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, BCL2, CA2, CHRM1, CHRM2, CYP1B1, KDR, KIT, MET, MMP12, MMP9, PIM1, SRC, TERT, XDH |
2.14228 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, XDH |
2.14112 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1 |
2.13312 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13225 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DYRK1A, KIT, PPARA, SRC |
2.11107 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.1102 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, SRC, TERT, XDH |
2.08416 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.08175 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DNMT1, IGF1R, MMP2, MMP9, SRC |
2.07552 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, PPARA |
2.05606 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DNMT1, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC |
2.05606 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC |
2.05606 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1B1, FABP3, PPARA, TBXAS1 |
2.03889 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CYP1B1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
2.02307 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1 |
2.00121 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, FLT3, IGF1R, KDR, KIT, MET, MMP2, PIM1, SRC, TERT |
3.06942 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, APP, AXL, BACE1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, FLT3, IGF1R, KDR, KIT, MET, SRC |
2.45867 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, CA4, CHRM1, CHRM2, CHRM4, FLT3, IGF1R, KDR, MET |
2.35997 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CYP19A1, CYP1A1, CYP1B1, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP2, PIM1, SRC, TBXAS1, TERT |
2.05606 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, CHRM1, CHRM2, CHRM4, FLT3, IGF1R, KDR, MET |
1.97986 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.4296 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DNMT1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TBXAS1, XDH |
9.01091 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TBXAS1, TERT, XDH |
8.47679 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.7397 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TBXAS1, TERT, XDH |
6.44292 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.98655 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.91676 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.87487 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CHRM1, CHRM2, CYP19A1, CYP1A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, PPARA, SRC |
4.65386 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.65202 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
4.19522 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.96042 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, MMP1, MMP12, MMP2, MMP9, PPARA |
3.89812 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DNMT1, KIT, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TBXAS1, TERT, XDH |
3.87669 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DNMT1, KIT, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TBXAS1, TERT, XDH |
3.48447 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1B1, TBXAS1, XDH |
3.21255 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
3.16132 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.67653 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.59709 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1B1, SRC, TBXAS1 |
2.5926 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1B1, SRC, TBXAS1 |
2.46211 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TERT |
2.45819 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1B1 |
2.42001 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.34429 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1B1 |
2.28919 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, FLT3, IGF1R, KDR, KIT, MET, PPARA |
2.05606 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1B1, TBXAS1 |
2.00121 |